These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 27600643

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. The State of Peptide Receptor Radionuclide Therapy and Its Sequencing among Current Therapeutic Options for Gastroenteropancreatic Neuroendocrine Tumors.
    Raymond LM, Korzun T, Kardosh A, Kolbeck KJ, Pommier R, Mittra ES.
    Neuroendocrinology; 2021; 111(11):1086-1098. PubMed ID: 33744879
    [Abstract] [Full Text] [Related]

  • 44. Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives.
    Zhang XB, Fan YB, Jing R, Getu MA, Chen WY, Zhang W, Dong HX, Dakal TC, Hayat A, Cai HJ, Ashrafizadeh M, Abd El-Aty AM, Hacimuftuoglu A, Liu P, Li TF, Sethi G, Ahn KS, Ertas YN, Chen MJ, Ji JS, Ma L, Gong P.
    Mil Med Res; 2024 Jun 04; 11(1):35. PubMed ID: 38835066
    [Abstract] [Full Text] [Related]

  • 45. Endoscopic techniques for diagnosis and treatment of gastro-entero-pancreatic neuroendocrine neoplasms: Where we are.
    Rossi RE, Elvevi A, Gallo C, Palermo A, Invernizzi P, Massironi S.
    World J Gastroenterol; 2022 Jul 14; 28(26):3258-3273. PubMed ID: 36051341
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Management of gastro-entero-pancreatic neuroendocrine tumours (GEP NET): an introduction.
    Van Hootegem P, Borbath I, Verslype C.
    Acta Gastroenterol Belg; 2009 Jul 14; 72(1):27-8. PubMed ID: 19402367
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Pavel M, Öberg K, Falconi M, Krenning EP, Sundin A, Perren A, Berruti A, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org.
    Ann Oncol; 2020 Jul 14; 31(7):844-860. PubMed ID: 32272208
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. The emerging role of targeted therapies for advanced well-differentiated gastroenteropancreatic neuroendocrine tumors.
    Cloyd JM, Konda B, Shah MH, Pawlik TM.
    Expert Rev Clin Pharmacol; 2019 Feb 14; 12(2):101-108. PubMed ID: 30582383
    [Abstract] [Full Text] [Related]

  • 53. Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management.
    Panzuto F, Massironi S, Partelli S, Campana D, Rinzivillo M, Invernizzi P, Andreasi V, Lamberti G, Falconi M.
    Surg Oncol; 2020 Dec 14; 35():141-148. PubMed ID: 32877883
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Imaging-guided precision medicine in non-resectable gastro-entero-pancreatic neuroendocrine tumors: A step-by-step approach.
    Rozenblum L, Mokrane FZ, Yeh R, Sinigaglia M, Besson FL, Seban RD, Zadro C, Dierickx L, Chougnet CN, Partouche E, Revel-Mouroz P, Zhao B, Otal P, Schwartz LH, Dercle L.
    Eur J Radiol; 2020 Jan 14; 122():108743. PubMed ID: 31783345
    [Abstract] [Full Text] [Related]

  • 58. Current role of Nuclear Medicine in the diagnosis and therapy of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Georgakopoulos A.
    Hell J Nucl Med; 2023 Jan 14; 26 Suppl():49-51. PubMed ID: 37658564
    [Abstract] [Full Text] [Related]

  • 59. [Diagnostics and treatment of neuroendocrine tumors of the digestive tract in the light of the present standards].
    Szczeblowska D.
    Pol Merkur Lekarski; 2007 May 14; 22(131):437-41. PubMed ID: 17679390
    [Abstract] [Full Text] [Related]

  • 60. New and emerging systemic therapy options for well-differentiated gastroenteropancreatic neuroendocrine tumors.
    Scoville SD, Cloyd JM, Pawlik TM.
    Expert Opin Pharmacother; 2020 Feb 14; 21(2):183-191. PubMed ID: 31760823
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.